Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print

Promotions & Moves

Related Searches:

Filter by:

Alba Therapeutics
October 3, 2008
Alba Therapeutics Corp. has made several promotions. Linda Arterburn, Ph.D., has been promoted to vice president of preclinical development and program management. Francisco Leon, M.D., Ph.D., has been promoted to vice president, clinical development…   Read More »
Bristol-Myers Squibb
October 2, 2008
Christopher Perley has been named vice president and general manager of Bristol-Myers Squibb's Devens biologics manufacturing facility. Mr. Perley will be responsible for continuing the supervision of the project to build the Devens facility and will…   Read More »
AMRI
October 1, 2008
Gergely Makara, Ph.D. has been named director of chemistry for European operations, AMRI. Dr. Makara has responsibility for all European chemistry products and services including custom synthesis, medicinal chemistry, analytical services, library des…   Read More »
ACORN
October 1, 2008
Tara Webb has been appointed senior director of business development, Accelerated Community Oncology Research Network (ACORN). Ms. Webb will focus exclusively in the field of oncology, working closely with a select group of sponsors.    &n…   Read More »
BASi
September 29, 2008
Jon Brewer has been named vice president, sales and marketing, BASi. He replaces Emilio Córdova who has resigned to pursue other opportunities. Mr. Brewer has nearly 25 years of experience as a sales and marketing executive in the pharmaceutic…   Read More »
AIT Laboratories
September 23, 2008
Ronald Shoup has been named executive director of Pharma Services, AIT Laboratories. Mr. Shoup was the former co-founder and chief scientific officer of West Lafayette, IN-based Bioanalytical Systems, Inc. (BASi). "Ron brings 30 years of lead…   Read More »
Girindus
September 22, 2008
John J. Dupree has joined Girindus as senior director, business development. Mr. Dupree has more than 34 years of sales, business management, and corporate accounts management experience. He spent his entire career with Eastman Chemical Co. as a seni…   Read More »
Wolfe Laboratories, Inc.
September 18, 2008
Roger Rush, Ph.D. has been named vice president of preclinical development, Wolfe Laboratories. Dr. Rush has more than 25 years of international experience in pharmaceutical R&D with a focus on preclinical research, development, and program manag…   Read More »
Millennium
September 17, 2008
Millennium (a.k.a. The Takeda Oncology Co.) has added Claire Thom, Pharm.D. as senior vice president, portfolio management and Isabelle Mercier as vice president, marketing for Millennium's commercial organization.     "We are…   Read More »
Sanofi-Aventis
September 10, 2008
Sanofi-Aventis has named Chris Viehbacher chief executive officer of the Group, effective December 1st, 2008. He succeeds Gerard Fur, who will continue to provide general management of the Group in the scientific area.     Mr. Vieh…   Read More »
Aptuit, Inc.
September 9, 2008
Thierry Amat has been appointed chief financial officer of Aptuit, Inc. Mr. Amat will oversee the financial and information technology departments. He has more than 20 years of financial management experience in publicly traded companies as well as k…   Read More »
AMRI
September 4, 2008
Steven R. Hagen, Ph.D. has been promoted to vice president of pharmaceutical development and manufacturing, AMRI. He will report to chairman, president and chief executive officer, Thomas E. D’Ambra, Ph.D. Luckner G. Ulysse, Jr., Ph.D. has been…   Read More »
Halozyme Therapeutics
September 2, 2008
Patrick O'Connor, Ph.D., has been appointed vice president, research, Halozyme Therapeutics. Michael J. LaBarre, Ph.D., has been appointed vice president, product development, and James E. Cartoni has been appointed vice president, legal.  &nbs…   Read More »
KPMG LLP
August 28, 2008
David Blumberg has joined KPMG LLP as a principal and advisory sector leader for the Pharmaceutical Industry practice, based in the firm’s Philadelphia office.     In his new role, Mr. Blumberg provides a full array of advisor…   Read More »
Aptuit
August 27, 2008
Timothy C. Tyson has been appointed executive chairman and acting chief executive officer of Aptuit, Inc. Michael A. Griffith, the company’s founder and chief executive officer since 2005, has resigned to pursue other opportunities.  &nbs…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: